Display options
Share it on

Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):853-857. doi: 10.4103/2230-8210.192898.

Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary).

Indian journal of endocrinology and metabolism

Mohammad Delwar Hossain, Jamal Uddin Ahmed, Muhammad Abdur Rahim, A K M Musa, Zafar Ahmed Latif

Affiliations

  1. Department of Internal Medicine and Pulmonology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.
  2. Department of Nephrology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.
  3. Department of Endocrinology, BIRDEM General Hospital and Ibrahim Medical College, Dhaka, Bangladesh.

PMID: 27867891 PMCID: PMC5105572 DOI: 10.4103/2230-8210.192898

Abstract

Tuberculosis (TB) and diabetes mellitus (DM) have synergetic relationship. People with diabetes are 2-3 times at higher risk of getting active TB disease. On the other hand, TB or anti-TB treatment may cause glucose intolerance. The dual disease of DM and TB is more likely to be associated with atypical disease presentation, higher probability of treatment failure and complications. In most of the health-care delivery systems of the world, DM and TB are managed separately by two vertical health-care delivery programs in spite of clear interaction between the two diseases. Thus, there should be a uniform management service for TB-DM co-morbidity. Realizing this situation, Bangladesh Diabetic Samity (BADAS), a nonprofit, nongovernment organization for the management of diabetes in Bangladesh, with the patronization of TB CARE II Project funded by U.S. Agency for International Development (USAID), launched a project in 2013 titled BADAS-USAID TB Care II, Bangladesh with the goal of "Integrated approach to increase access to TB services for diabetic patients." One of the project objective and activity was to develop a national guideline for the management of TB-DM comorbidity. Thus, under the guidance of National Tuberculosis Control Program, of the Directorate General of Health Services, Government of the People's Republic of Bangladesh and World Health Organization (WHO), this guideline was developed in 2014. It is based on the existing "National Guidelines and Operational Manual for TB Control" (5

Keywords: Bangladesh; co-morbidity; diabetes mellitus; guidelines; tuberculosis

References

  1. PLoS Med. 2008 Jul 15;5(7):e152 - PubMed
  2. Am J Epidemiol. 2008 Jun 15;167(12):1486-94 - PubMed
  3. Trop Med Int Health. 2010 Nov;15(11):1289-99 - PubMed
  4. Int J Tuberc Lung Dis. 2006 Jan;10(1):74-9 - PubMed
  5. Diabetes Care. 2012 Jun;35(6):1364-79 - PubMed
  6. J Clin Invest. 1990 Jun;85(6):1896-904 - PubMed
  7. BMC Public Health. 2007 Sep 06;7:234 - PubMed
  8. Am Rev Respir Dis. 1982 Jan;125(1):23-7 - PubMed
  9. Infect Dis Clin North Am. 1995 Mar;9(1):65-96 - PubMed
  10. Respiration. 2001;68(6):595-600 - PubMed
  11. J Assoc Physicians India. 2009 May;57:399-404 - PubMed
  12. Infect Dis Clin North Am. 1995 Mar;9(1):1-9 - PubMed
  13. Int J Tuberc Lung Dis. 2006 Jun;10(6):696-700 - PubMed
  14. Am J Trop Med Hyg. 2008 Oct;79(4):541-4 - PubMed
  15. Tubercle. 1990 Dec;71(4):271-6 - PubMed
  16. Diabetes Metab J. 2013 Aug;37(4):291-5 - PubMed
  17. Clin Infect Dis. 2007 Aug 15;45(4):428-35 - PubMed

Publication Types